These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 13666531)

  • 1. [Curative & preventive treatment of amnionitis with 3,4-dimethyl-5-sulfanilamido-isoxazole].
    MASSANO A; MUSSO G
    Minerva Ginecol; 1959 Apr; 11(8):343-5. PubMed ID: 13666531
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early results of 3,4-dimethyl-5-sulfanilamido-isoxazole therapy of acute and chronic infections of the lung].
    ANNEDDA L; ROMAGNANI L
    Gazz Med Ital; 1953 May; 112(5):146-9. PubMed ID: 13083873
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood levels in relation to dosage of 3,4 dimethyl-5 sulfanilamido-isoxazole (gantrisin) in children with clinical observations.
    PRICE PC; HANSEN AE
    Tex Rep Biol Med; 1951; 9(4):764-79. PubMed ID: 14901327
    [No Abstract]   [Full Text] [Related]  

  • 4. [Case of South American blastomycosis of the lungs treated with 6-sulfanilamido-2,4-dimethyl-pyrimidine].
    PASSOS FILHO MC
    Hospital (Rio J); 1958 May; 53(5):651-72. PubMed ID: 13562768
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological and chemotherapeutic properties of 3,4-dimethyl-5-sulfanilamido-isoxazole.
    SCHNITZER RJ; FOSTER RH
    J Pharmacol Exp Ther; 1946 Sep; 88(1):47-57. PubMed ID: 20274525
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with a new sulfonamide, 5-methyl-3-sulfanilamido-isoxazole.
    CABEZON J; PRIGOT A; MEDINA A
    Curr Ther Res Clin Exp; 1962 Oct; 4():506-12. PubMed ID: 14017551
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of leprosy with 2-sulfanilamido-3-methoxypyrazine (SMPz)].
    Alonso AM
    Rev Bras Med; 1965 May; 22(5):313-20. PubMed ID: 5841420
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of South America blastomycosis of pulmonary localization with 6-sulfanilamido-2,4-dimethylpyrimidine; diagnosis & clinical evolution].
    PASSOS FILHO MC; NAHAS L
    Hospital (Rio J); 1959 Feb; 55(2):237-63. PubMed ID: 13640539
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapeutic activity of 6-sulfanilamido-4-methoxypyrimidine in acute bacterial infections].
    Padeĭskaia EN; Polukhina LM; Pershin GN
    Farmakol Toksikol; 1966; 29(4):472-7. PubMed ID: 5987504
    [No Abstract]   [Full Text] [Related]  

  • 10. [2-Sulfanilamido-3-methoxypyrazine in the treatment of various inflammatory forms of the female genital tract].
    DE CECCO L
    Clin Ter; 1963 Mar; 24():543-51. PubMed ID: 14025743
    [No Abstract]   [Full Text] [Related]  

  • 11. Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
    Girisha HR; Narendra Sharath Chandra JN; Boppana S; Malviya M; Sadashiva CT; Rangappa KS
    Eur J Med Chem; 2009 Oct; 44(10):4057-62. PubMed ID: 19493592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl celecoxib as a novel non-cyclooxygenase 2 therapy in the treatment of non-small cell lung cancer.
    Backhus LM; Petasis NA; Uddin J; Schönthal AH; Bart RD; Lin Y; Starnes VA; Bremner RM
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1406-12. PubMed ID: 16256796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dimorphismus of 2-sulfanilamido-5-methoxypyrimidine (sulfamethoxydine)].
    Svátek E; Knobloch E; Budĕsínský Z
    Cesk Farm; 1966 Nov; 15(9):470-3. PubMed ID: 5978732
    [No Abstract]   [Full Text] [Related]  

  • 14. [Some unusual pharmaco-dynamic properties of 3-sulfanilamido-6-methoxypyridazine].
    QUATTRIN N; BRANCACCIO A; JACONO G
    Rass Fisiopatol Clin Ter; 1958 Feb; 30(2):101-18. PubMed ID: 13542827
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the pharmacology of 3-sulfanilamido-2-phenyl-pyrazole].
    CUGURRA F; BRAMBILLA G
    Boll Soc Ital Biol Sper; 1959 Jun; 35(11):605-7. PubMed ID: 13671152
    [No Abstract]   [Full Text] [Related]  

  • 16. [JUPITER study, more reason to give statins as preventive measure - commentary].
    Narkiewicz K
    Kardiol Pol; 2009 Mar; 67(3):346-7. PubMed ID: 19469067
    [No Abstract]   [Full Text] [Related]  

  • 17. [Remarks on the use of 3, 4-dimethyl-5-sulfanilamidoisoxazole in various morbid forms].
    MONTANARI G
    Gazz Med Ital; 1958 Jul; 117(7):300-2. PubMed ID: 13574388
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacology of 2-sulfanilamido-5-methoxypyrimidine].
    HECHT G; JUNKMANN K; LANGECKER H; GLOXHUBER C; HARWART A; WIRTZ S
    Arzneimittelforschung; 1961 Aug; 11():695-700. PubMed ID: 14036116
    [No Abstract]   [Full Text] [Related]  

  • 19. [Solubility and acidity of 2-sulfanilamido-4,5-dimethyloxazole].
    DELFS FM; LOOP W
    Arzneimittelforschung; 1961 Apr; 11():402-3. PubMed ID: 13721551
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic activity of 2-sulfanilamido-3-methoxypyrazine in some dermatological diseases].
    CALIFANO A
    Minerva Med; 1961 May; 52():1817-9. PubMed ID: 13689962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.